Clinical Trial Update: Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating upfront haploidentical or unrelated donor bone marrow transplantation to restore normal hematopoiesis in severe aplastic ane…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Severe Aplastic Anemia | Phase 2 | Status: RECRUITING